US20040053880A1 - Nucleic acid compositions for stimulating immune responses - Google Patents

Nucleic acid compositions for stimulating immune responses Download PDF

Info

Publication number
US20040053880A1
US20040053880A1 US10/613,739 US61373903A US2004053880A1 US 20040053880 A1 US20040053880 A1 US 20040053880A1 US 61373903 A US61373903 A US 61373903A US 2004053880 A1 US2004053880 A1 US 2004053880A1
Authority
US
United States
Prior art keywords
nucleic acid
cancer
method
antigen
immunostimulatory nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/613,739
Inventor
Arthur Krieg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coley Pharmaceutical Group inc
Original Assignee
Coley Pharmaceutical Group inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US39388002P priority Critical
Application filed by Coley Pharmaceutical Group inc filed Critical Coley Pharmaceutical Group inc
Priority to US10/613,739 priority patent/US20040053880A1/en
Assigned to COLEY PHARMACEUTICAL GROUP reassignment COLEY PHARMACEUTICAL GROUP ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KRIEG, ARTHUR M
Publication of US20040053880A1 publication Critical patent/US20040053880A1/en
Assigned to PFIZER INC. reassignment PFIZER INC. CONFIRMATION OF EXCLUSIVE PATENT LICENSE Assignors: COLEY PHARMACEUTICAL GROUP, INC., COLEY PHARMACEUTICAL GROUP, LTD., COLEY PHARMACEUTICAL, GMBH
Abandoned legal-status Critical Current

Links